Solid Biosciences Llc Stock Net Income
| SLDB Stock | USD 10.10 0.13 1.27% |
Solid Biosciences LLC fundamentals help investors to digest information that contributes to Solid Biosciences' financial success or failures. It also enables traders to predict the movement of Solid Stock. The fundamental analysis module provides a way to measure Solid Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Solid Biosciences stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -90.8 M | -95.4 M | |
| Net Loss | -77.4 M | -81.3 M | |
| Net Loss | -96 M | -100.8 M | |
| Net Loss | (4.83) | (5.07) | |
| Net Income Per E B T | 0.88 | 1.03 |
Solid | Net Income |
Solid Biosciences LLC Company Net Income Analysis
Solid Biosciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Solid Biosciences Net Income | (96.02 M) |
Most of Solid Biosciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Solid Biosciences LLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Solid Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Solid Biosciences is extremely important. It helps to project a fair market value of Solid Stock properly, considering its historical fundamentals such as Net Income. Since Solid Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Solid Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Solid Biosciences' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Solid Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Solid Biosciences LLC reported net income of (96.02 Million). This is 128.13% lower than that of the Biotechnology sector and 237.07% lower than that of the Health Care industry. The net income for all United States stocks is 116.82% higher than that of the company.
Solid Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Solid Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Solid Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Solid Biosciences' value.| Shares | Bmo Capital Markets Corp. | 2023-12-31 | 131.5 K | Walleye Trading Advisors, Llc | 2023-12-31 | 124.6 K | Blackrock Inc | 2023-12-31 | 114.1 K | Geode Capital Management, Llc | 2023-12-31 | 93.5 K | Bridgeway Capital Management, Llc | 2023-12-31 | 51.1 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 50 K | State Street Corporation | 2023-12-31 | 44.6 K | Renaissance Technologies Corp | 2023-12-31 | 38.1 K | Two Sigma Investments Llc | 2023-12-31 | 37.2 K | Perceptive Advisors Llc | 2023-12-31 | 3.5 M | Ra Capital Management, Llc | 2023-12-31 | 3.4 M |
Solid Fundamentals
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | 283.97 M | ||||
| Shares Outstanding | 37.86 M | ||||
| Shares Owned By Insiders | 0.78 % | ||||
| Shares Owned By Institutions | 75.77 % | ||||
| Number Of Shares Shorted | 1.05 M | ||||
| Price To Book | 3.10 X | ||||
| Price To Sales | 3.65 X | ||||
| Gross Profit | 13.62 M | ||||
| EBITDA | (101.73 M) | ||||
| Net Income | (96.02 M) | ||||
| Cash And Equivalents | 162.88 M | ||||
| Cash Per Share | 1.44 X | ||||
| Total Debt | 26.27 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 7.85 X | ||||
| Book Value Per Share | 6.20 X | ||||
| Cash Flow From Operations | (94.18 M) | ||||
| Short Ratio | 3.24 X | ||||
| Earnings Per Share | (4.83) X | ||||
| Target Price | 17.0 | ||||
| Number Of Employees | 88 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 382.39 M | ||||
| Total Asset | 164.94 M | ||||
| Retained Earnings | (658.75 M) | ||||
| Working Capital | 115.22 M | ||||
| Net Asset | 164.94 M |
About Solid Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Solid Biosciences LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Solid Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Solid Biosciences LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Solid Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Solid Biosciences' short interest history, or implied volatility extrapolated from Solid Biosciences options trading.
Currently Active Assets on Macroaxis
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out Solid Biosciences Piotroski F Score and Solid Biosciences Altman Z Score analysis. Note that the Solid Biosciences LLC information on this page should be used as a complementary analysis to other Solid Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Solid Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.83) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.57) |
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.